2024年9月12日 · PPSV23. Vaccine providers may give PPSV23 to children 2 through 18 years old with certain conditions. Vaccine providers give it to adults who receive PCV15. They also may give it to adults who have received an earlier vaccine called PCV13. Pneumovax23 ® (PPSV23) helps protect against 23 types of pneumococcal bacteria.

2015年9月4日 · On June 25, 2015, ACIP changed the recommended interval between PCV13 followed by PPSV23 (PCV13–PPSV23 sequence) from 6–12 months to ≥1 year for immunocompetent adults aged ≥65 years. Recommended intervals for all other age and risk groups remain unchanged.

2019年10月30日 · Most people need only one dose of PPSV23. A second dose of PPSV23, and another type of pneumococcal vaccine called PCV13, are recommended for certain high-risk groups. Your health care provider can give you more information.

2022年5月3日 · In contrast, PPSV23, a capsular polysaccharide vaccine that induces an immune response via release of immunoglobulin from B cells, does not result in mucosal immunity, and protection wanes over...

2023年8月23日 · Using PCV13 or PCV15 (no PCV20): A dose of PCV20 or PPSV23 using previously recommended doses and schedule is recommended. † Recommendations are of particular importance for children with cyanotic congenital heart disease and cardiac failure.

• PCV13 (pneumococcal conjugate vaccine) protects against 13 of the approximately 90 types of pneumococcal bacteria that can cause pneumococcal disease, including pneumonia, meningitis, and bacteremia. • PPSV23 (pneumococcal polysaccharide vaccine) protects against 23 types of pneumococcal bacteria. This vaccine helps

2015年9月4日 · The recommended intervals between PCV13 and PPSV23 given in series differ by age and risk group and the order in which the two vaccines are given (1-4).

This report outlines the new recommendations for PCV13 use, provides guidance for use of PCV13 and PPSV23 among adults aged ≥65 years, and summarizes the evidence considered by ACIP to make this recommendation.

PCV13 should be administered at least 8 weeks after the most recent dose of PCV7 or PPSV23. A dose of PCV13 should be given at least 1year following a dose of PPSV23. The two vaccines should not be co-administered. If a dose of PCV13 is given earlier than the recommended interval, the dose need not be repeated.

Pneumococcal polysaccharide vaccine 23 (PPSV 23) is the first pneumococcal vaccine to be discovered. Immunisation with PPSV 23 is recommended for children or adults with serious threats, and not in routine vaccination schedules.